Literature DB >> 19672992

Clinical and genetic characteristics of Mexican Huntington's disease patients.

María Elisa Alonso1, Adriana Ochoa, Marie-Catherine Boll, Ana Luisa Sosa, Petra Yescas, Marisol López, Rosario Macias, Itziar Familiar, Astrid Rasmussen.   

Abstract

We report the characteristics of 691 Mexican patients with Huntington's disease (HD). These patients, representing 401 families, constitute the largest series of Mexican HD cases as yet described in the literature. We found the clinical characteristics of these patients to be similar to those of other populations, but we observed a higher frequency of infantile cases, a shorter disease duration and a lower suicide rate. In 626 cases, for which molecular analyses were available, CAG-trinucleotide expansion size ranged from 37-106 repeats. The large number of CAG repeats (19.04 +/- 3.02) in normal alleles and the presence of new mutations suggest that the overall prevalence of HD in the Mexican population could be expected to be within range of, or higher than, that reported for Europeans.

Entities:  

Mesh:

Year:  2009        PMID: 19672992     DOI: 10.1002/mds.22737

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

1.  Suicidal behavior in prodromal Huntington disease.

Authors:  Jess G Fiedorowicz; James A Mills; Adam Ruggle; Douglas Langbehn; Jane S Paulsen
Journal:  Neurodegener Dis       Date:  2011-06-09       Impact factor: 2.977

Review 2.  Treatment of Huntington's disease.

Authors:  Samuel Frank
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

3.  Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease.

Authors:  Samuel Frank
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-05       Impact factor: 2.570

Review 4.  Evaluating the current state of the art of Huntington disease research: a scientometric analysis.

Authors:  L A Barboza; N C Ghisi
Journal:  Braz J Med Biol Res       Date:  2018-01-11       Impact factor: 2.590

5.  Clinical and Genetic Profiles in Chinese Patients with Huntington's Disease: A Ten-year Multicenter Study in China.

Authors:  Hong-Lei Li; Xiao-Yan Li; Yi Dong; Yan-Bin Zhang; Hong-Rong Cheng; Shi-Rui Gan; Zhi-Jun Liu; Wang Ni; Jean-Marc Burgunder; X William Yang; Zhi-Ying Wu
Journal:  Aging Dis       Date:  2019-10-01       Impact factor: 6.745

6.  Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.

Authors:  Martina Petracca; Sonia Di Tella; Marcella Solito; Paola Zinzi; Maria Rita Lo Monaco; Giulia Di Lazzaro; Paolo Calabresi; Maria Caterina Silveri; Anna Rita Bentivoglio
Journal:  Eur J Neurol       Date:  2022-04-17       Impact factor: 6.288

7.  Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease.

Authors:  Astrid Rasmussen; Elisa Alonso; Adriana Ochoa; Irene De Biase; Itziar Familiar; Petra Yescas; Ana-Luisa Sosa; Yaneth Rodríguez; Mireya Chávez; Marisol López-López; Sanjay I Bidichandani
Journal:  BMC Med Genet       Date:  2010-01-12       Impact factor: 2.103

8.  The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-Analysis.

Authors:  Oliver Quarrell; Kirsty L O'Donovan; Oliver Bandmann; Mark Strong
Journal:  PLoS Curr       Date:  2012-07-20

Review 9.  What do we know about Late Onset Huntington's Disease?

Authors:  Sai S Chaganti; Elizabeth A McCusker; Clement T Loy
Journal:  J Huntingtons Dis       Date:  2017
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.